首页> 外文期刊>DNA and Cell Biology >Crosstalk Between the Microbiome and Gestational Immunity in Autism-Related Disorders
【24h】

Crosstalk Between the Microbiome and Gestational Immunity in Autism-Related Disorders

机译:在自闭症相关疾病中微生物组和妊娠期免疫之间的串扰

获取原文
获取原文并翻译 | 示例
           

摘要

The etiologies of most neurodevelopmental disorders, including autism spectrum disorder (ASD), remain incompletely understood. However, recent epidemiological and experimental data suggest that dysregulated maternal immune activation (MIA) can impede normal brain maturation and promote the development of autism-related phenotypes. Indeed, our studies and work by others demonstrate that offspring born to pregnant animals that were exposed to immune activators develop many of the defining behavioral features of ASD, including abnormalities in social preference, communicative impairments, and repetitive/stereotyped behaviors. Although mounting evidence implicates key roles for hyperactive gestational inflammatory responses in neurodevelopmental disorders, the specific immune pathways that provoke autism-related phenotypes remain poorly described. The microbiome is recognized as a key modulator of immune responses, and emerging studies suggest that microbiota composition is a pivotal regulator of central nervous system function and disease. There has been growing speculation that changes in human microflora diversity contribute at some level to the recent rise in autism incidence. This has largely stemmed from reports of dysbiosis and gastrointestinal inflammation in autistic individuals. Given these clinical findings and the well-described role of the microbiome in calibrating the immune system, our group and others have recently become interested in investigating how changes in microbiota landscape influence neurodevelopmental disorder pathogenesis. In this review, we highlight emerging data describing roles for microbiota in the development of autism-related behavioral abnormalities. These recent findings identify the immune system as a link between gut microbiota and the brain in neurodevelopmental disorders, and suggest that targeting the microbiome and maternal immune responses during gestation may offer strategies to limit autism development in at-risk pregnancies.
机译:大多数神经发育障碍的病因,包括自闭症谱系障碍(ASD),保持不完全理解。然而,最近的流行病学和实验数据表明,失调的母体免疫激活(MIA)可以妨碍正常的脑成熟并促进与自闭症相关表型的发展。实际上,我们的研究和工作向其他人证明了出生于暴露于免疫激活者的怀孕动物的后代发展了asd的许多定义行为特征,包括社会偏好,交际障碍和重复/陈规定型行为的异常。虽然安装证据含义对神经发育疾病中有过活性妊娠炎症反应的关键作用,但挑起自闭症相关表型的特异性免疫途径仍然仍然清楚。微生物组被认为是免疫反应的关键调节剂,新兴研究表明,微生物群组合物是中枢神经系统功能和疾病的枢轴调节因子。人们越来越大的猜测,人类微生物变化的变化在某种程度上有助于近期自闭症发病率的上升。这主要源于自闭症中患有困难和胃肠炎症的报道。鉴于这些临床发现和微生物组在校准免疫系统中的良好描述的作用,我们的组和其他人最近对研究微生物群景观影响的变化影响神经发育障碍发病机制。在本次综述中,我们突出了新兴数据描述了微生物群在自闭症相关行为异常发展中的作用。这些最近的发现将免疫系统鉴定为肠道微生物肿瘤和神经发育障碍的大脑之间的联系,并表明妊娠中的微生物组和母体免疫反应可能提供限制风险妊娠中自闭症发育的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号